The U.S. Justice Dept. and ArthroCare agree to another extension of their deferred prosecution deal as they try to hash out a deal to settle a probe into ArthroCare’s spinal business.
ArthroCare (NSDQ:ARTC) and the U.S. Justice Dept. gave themselves until the end of May to hash out a deal over a criminal probe into ArthroCare’s spinal business.
It’s the 3rd extension of a so-called tolling agreement between the Austin, Texas-based medical device company and the feds that lengthens the the statute of limitations on the investigation.
ArthroCare said again that it can’t predict the outcome of the negotiations and “is unable to estimate any potential liability the company may incur, according to a regulatory filing.
